Kendall Capital Partners
About
Kendall Capital Partners is a next-generation venture capital firm headquartered in Boston, focusing on early-to-commercial stage life sciences and healthcare companies. The firm partners with world-class founders, scientific labs, and institutions to transform deep science into scalable businesses, with a mandate to back breakthroughs, build enduring companies, and deliver health impact at scale. They invest in disruptive and durable scientific breakthroughs with the potential to reshape global healthcare and deliver outsized returns.
Key facts
At-a-glance profile data
- Website
- kcpventures.com
- Type
- VC
- Headquarters
- Boston, United States
- Funds raised
- $9M
- Portfolio companies
- 2
- Stages
- Series BSeedSeries A
- Cheque size
- $17M to $100M
- Sector focus
- BiotechnologyLife SciencesHealthcareDrug DiscoveryDiagnostics
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 20 Jun 2024 | Profluent | Series B | $100M |
| 21 May 2024 | Profluent | Undisclosed round | $35M |
| 10 Oct 2023 | Profluent | Series A | $35M |
| 1 Oct 2022 | Profluent | Undisclosed round | $9M |
| 3 May 2019 | BluWireless Technology | Series B | $17M |
Add first review
Frequently asked
What companies has Kendall Capital Partners invested in?
Kendall Capital Partners has invested in Profluent, BluWireless Technology.